- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4168 - 1,3-Diazoles having a nitrogen atom attached in position 2, e.g. clonidine
Patent holdings for IPC class A61K 31/4168
Total number of patents in this class: 559
10-year publication summary
|
46
|
47
|
49
|
42
|
48
|
47
|
37
|
25
|
40
|
13
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Warsaw Orthopedic, Inc. | 2755 |
21 |
| Allergan, Inc. | 2155 |
16 |
| Rivus Pharmaceuticals, Inc. | 17 |
14 |
| Race Oncology Ltd. | 20 |
12 |
| The Regents of the University of California | 20842 |
11 |
| The Scripps Research Institute | 1344 |
8 |
| vTv Therapeutics LLC | 150 |
8 |
| Alcon, Inc. | 5910 |
6 |
| Ligand Pharmaceuticals Incorporated | 168 |
6 |
| ThermoLife International, LLC | 186 |
6 |
| Ic-medtech Corporation | 20 |
5 |
| Noven Pharmaceuticals, Inc. | 87 |
5 |
| Vireo Systems, Inc. | 72 |
5 |
| Theravet, société anonyme | 13 |
5 |
| Merck Sharp & Dohme LLC | 3738 |
5 |
| Centre National de La Recherche Scientifique | 11077 |
4 |
| Buck Institute for Research on Aging | 128 |
4 |
| Eye Therapies LLC | 43 |
4 |
| North Carolina State University | 1596 |
4 |
| POLA Pharma Inc. | 72 |
4 |
| Other owners | 406 |